Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government

NEXT STORY
Boehringer Ingelheim and OSE Immunotherapeutics to Present Phase 1 Results with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors at ESMO 2021
PREV STORY
MacroGenics Announces Presentations at ESMO 2021 Virtual Annual Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event

author_avatar
NASDAQ Market News

Ocera Therapeutics Appoints Biopharmaceutical Veteran Willard Dere, M.D. to Board of Directors

PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 28, 2016 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News

Triphase Accelerator Corporation Announces Positive Results of Phase 1 Trial of Marizomib and Bevacizumab in Malignant Glioma

TORONTO and SAN DIEGO, June 04, 2016 (GLOBE NEWSWIRE) -- Triphase Accelerator Corporation, a ...

author_avatar
NASDAQ Market News